(Q42280386)

19 October 2017

title

Lifibrol: a novel lipid-lowering drug for the therapy of hypercholesterolemia. Lifibrol Study Group (English)

1 reference

19 October 2017

0 references

Locker PK

1

1 reference

19 October 2017

Jungbluth GL

series ordinal

2

1 reference

19 October 2017

Francom SF

series ordinal

3

1 reference

19 October 2017

Hughes GS Jr

series ordinal

4

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

Clinical Pharmacology & Therapeutics

19 October 2017

published in

1 reference

19 October 2017

volume

57

1 reference

19 October 2017

issue

1

1 reference

19 October 2017

page(s)

73-88

1 reference

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990269-4

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990269-4

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990269-4

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990269-4

10.1016/0009-9236(95)90269-4

21 January 2018

Identifiers

DOI

1 reference

19 October 2017

1 reference